Carrie E. Carlander McQueen
Directeur/Membre du Conseil chez Forest Home Foundation
Profil
Ms. Carrie E.
McQueen is Chief Financial & Accounting Officer at Social Reality, Inc. She is on the Board of Directors at Forest Home Foundation.
Ms. McQueen was previously employed as Chief Financial Officer & Treasurer by LifeVantage Corp.
and Chief Financial Officer & Treasurer by Adventrx Pharmaceuticals, Inc.
She received her undergraduate degree from the University of California San Diego and an MBA from San Diego State University.
Postes actifs de Carrie E. Carlander McQueen
| Sociétés | Poste | Début |
|---|---|---|
| Forest Home Foundation | Directeur/Membre du Conseil | - |
Anciens postes connus de Carrie E. Carlander McQueen
| Sociétés | Poste | Fin |
|---|---|---|
| LIFEVANTAGE CORPORATION | Directeur Financier/CFO | 01/08/2012 |
Mast Therapeutics, Inc.
 Mast Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Mast Therapeutics, Inc. is a biopharmaceutical company, which engages in developing novel therapies for serious or life-threatening diseases with significant unmet needs. It leveraging Molecular Adhesion and Sealant Technology, platform, derived from over two decades of clinical, nonclinical, and manufacturing experience with purified and non-purified poloxamers to develop vepoloxamer, which also known as MST-188. The company was founded by Warren C. Lau in December 1995 and is headquartered in San Diego, CA. | Directeur Financier/CFO | 05/09/2006 |
| SRAX, INC. | Directeur Financier/CFO | 13/04/2016 |
Formation de Carrie E. Carlander McQueen
| San Diego State University | Masters Business Admin |
| University of California San Diego | Undergraduate Degree |
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 2 |
|---|---|
| LIFEVANTAGE CORPORATION | Health Technology |
| SRAX, INC. | Technology Services |
| Entreprise privées | 2 |
|---|---|
Mast Therapeutics, Inc.
Mast Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Mast Therapeutics, Inc. is a biopharmaceutical company, which engages in developing novel therapies for serious or life-threatening diseases with significant unmet needs. It leveraging Molecular Adhesion and Sealant Technology, platform, derived from over two decades of clinical, nonclinical, and manufacturing experience with purified and non-purified poloxamers to develop vepoloxamer, which also known as MST-188. The company was founded by Warren C. Lau in December 1995 and is headquartered in San Diego, CA. | Health Technology |
| Forest Home Foundation |